Moneycontrol PRO
Check Credit Score
Check Credit Score
chakra

Countdown to Lok Sabha Elections 2024

voteFULL COVERAGE
HomeNewsBusiness

McLeod Russel staring at 5.5-million kg production loss in FY21 amid COVID-19 pandemic

The company's usual production volume is close to 52 million kg, out of which nearly eight million kg are purchased from small growers.

May 18, 2020 / 06:48 PM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

McLeod Russel, the country's largest bulk producer of tea, is expecting a decline in production by around 5.5 million kg in the current fiscal due to the COVID-19 pandemic, a company official said on Monday.

The company's usual production volume is close to 52 million kg, out of which nearly eight million kg are purchased from small growers.

"Last year, across Assam and West Bengal, our own production volume was 46 million kg. We bought additionally around six million kg from small growers," Wholetime Director of McLeod Russel Azam Monem said.

He said this year, as the gardens suffered production loss in March and the whole of April due to the coronavirus lockdown, only some skiffing activity only took place.

"So far, our own production loss is around 4 million kg and we will be able to purchase only 1.5 million kg from small growers," Monem told PTI.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The tea industry's production loss will be around 115 million kg this year, while in terms of revenue, the figure is likely to be Rs 2,000 crore, he said.

McLeod Russel's loss will be nearly Rs 85 crore in the current fiscal, the company official said.

"We hope to make some recovery in June and July. We want to protect the valuable second flush that comes from the middle of May," Monem said.

While Assam has allowed 100 per cent workforce in tea gardens, the West Bengal government has given consent for only 50 per cent, he said.

"We have approached the state government for allowing 100 per cent workforce," he added.

The Williamson Magor Group company has 31 gardens in Assam and two in north Bengal.

Monem said the government should provide some financial stimulus in the form of enhanced working capital limit from banks in this challenging scenario.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: May 18, 2020 06:44 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347